Virtual Reality’s Impact: Apple’s Vision Pro Sparks Debate
Apple's release of the Vision Pro VR headset opens up new possibilities for immersive experiences, but concerns about inappropriate use ...
- Latest
- Trending
Apple's release of the Vision Pro VR headset opens up new possibilities for immersive experiences, but concerns about inappropriate use ...
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...
The global Assisted Reproductive Technology market is projected to grow by $8.23 billion by 2027, driven by rising infertility rates ...
Innovations in brain-computer interfaces aim to revolutionize mental health treatments. Find out the strengths, weaknesses, opportunities, and threats of this ...
Johnson & Johnson's $2 billion acquisition of Ambrx Biopharma emphasizes its focus on oncology and targeted cancer treatments. #PharmaNews
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.